Comparison of the effect of metoclopramide and dexamethasone with androsterone and midazolam in the prevention of nausea and vomiting during and after cesarean section

Comparison of the effect of combination of Metoclopramide and Dexamethasone with Ondrosterone and Midazolam in the prevention of nausea and vomiting during and after cesarean section patients with spinal anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190901044658N2

Enrollment

150

Registered

2020-06-22

Start date

2020-03-20

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean section. Encounter for full-term uncomplicated delivery

Interventions

Intervention 1: Intervention group1: This group includes 75 pregnant women with cesarean section indications. To this group, metoclopramide ampoules will be injected into patients 10 mg intravenously

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having a cesarean surgery indication

Exclusion criteria

Exclusion criteria: Having Chronic disease Drug addiction

Design outcomes

Primary

Measure	Time frame
Vomiting. Timepoint: Before cesarean section and after cesarean section. Method of measurement: Number of patients vomit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahla Farzipour

Ardabil University of Medical Sciences

meisamfooladi@gmail.com+98 45 3323 0739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026